ASRTAssertio Holdings, Inc.
23.43USD-0.00%Mkt Cap: 151.41M USDP/E: Last update: 2026-06-01

Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate t…

Indicators:|

Key Statistics

Company
Market Cap151.41M USD
Enterprise Value120.22M USD
Revenue (TTM)102.16M USD
Gross Profit83.33M USD
Net Income (TTM)-30.38M USD
Revenue/Share15.92 USD
Last Price23.43 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees53
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINLU1953136287
Valuation
P/E (Trailing)
P/E (Forward)9.09
PEG0.89
EV/EBITDA31.41
EV/Revenue1.18
P/S1.48
P/B2.00
EPS (TTM)-5.55
EPS (Forward)2.58
52W Range
8.610100% of range23.46
52W High23.46 USD
52W Low8.610 USD
Profitability
Gross Margin70.19%
Oper. Margin-185.95%
EBITDA Margin3.75%
Profit Margin-25.59%
ROE-32.33%
ROA-11.38%
Growth
Revenue Growth-62.50%
Earnings Growth
Cash Flow & Leverage
Operating CF-28.18M USD
CapEx (TTM)
FCF Margin7.59%
FCF Yield5.12%
Net Debt-31.26M USD
Net Debt/EBITDA-8.17
Balance Sheet
Debt/Equity0.43
Current Ratio1.82
Quick Ratio1.45
Book Value/Sh11.73 USD
Cash/Share11.07 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:15
Split DateDec 26, 2025
Analyst Consensus
Rating
Target (Mean)24.43 USD
Target Range21.80 USD28.00 USD
# Analysts3
Ownership
Shares Out.6.46M
Float5.57M
Insiders1.97%
Institutions39.94%
Short Interest
Short Ratio0.6d
Short % Float3.91%
Short % Out.3.86%
Shares Short249.30K
Short (prev mo.)287.24K
Technical
SMA 5019.64 (+19.3%)
SMA 20013.76 (+70.3%)
Beta0.45
S&P 52W Chg27.94%
Avg Vol (30d)388.65K
Avg Vol (10d)336.38K
Technical Indicators
RSI (14)85.6
MACD1.2270
MACD Signal1.3823
MACD Hist.-0.1552
BB Upper25.06 USD
BB Middle22.74 USD
BB Lower20.42 USD
BB Width20.40%
ATR (14)0.2766 USD
Vol Ratio (20d)0.09x